Decoy Therapeutics DCOY
NASDAQ DCOY
$1.08 -0.06 (-5.29%)
As of: Oct 21, 2026 · 3:55 PM EDT

Decoy Therapeutics (DCOY) EV to CFO (2018 - 2019)

Updated

Decoy Therapeutics' (DCOY) EV to CFO stood at 338.26 in Q2 2019, down 8.9% from the prior quarter.

Analysis

Decoy Therapeutics (DCOY) EV to CFO (2018 - 2019) Analysis & Trends

On a TTM basis, Decoy Therapeutics' EV to CFO came in at 337.69 as of Jun 30, 2019; for FY2018, it came in at 891.32.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Decoy Therapeutics 571,865.63 -31.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 338.26
Mar 31, 2019 371.29
Dec 31, 2018 891.32
API Access

Decoy Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=DCOY&period=max&api_key=YOUR_API_KEY